New Thiouracil Derivatives As Histone Deacetylase Inhibitors and Apoptosis Inducers: Design, Synthesis and Anticancer Evaluation

References

• Maj E , PapiernikD , WietrzykJ. Antiangiogenic cancer treatment: the great discovery and greater complexity. Int. J. Oncol.49(5), 1773–1784 (2016).
   PubMed Web of Science ®Google Scholar
• El-Helby AGA , SakrH , EissaIH , Al-KarmalawyAA , El-AdlK. Benzoxazole/benzothiazole-derived VEGFR-2 inhibitors: design, synthesis, molecular docking, and anticancer evaluations. Arch. Pharm.352(12), 1900178 (2019).
   Web of Science ®Google Scholar
• Vasudev NS , ReynoldsAR. Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions. Angiogenesis17, 471–494 (2014).
   PubMed Web of Science ®Google Scholar
• Alanazi MM , ElkadyH , AlsaifNAet al. New quinoxaline-based VEGFR-2 inhibitors: design, synthesis, and antiproliferative evaluation with in silico docking, ADMET, toxicity, and DFT studies. RSC Adv.11(48), 30315–30328 (2021).
   PubMed Web of Science ®Google Scholar
• Deng B , LuoQ , HalimA , LiuQ , ZhangB , SongG. The antiangiogenesis role of histone deacetylase inhibitors: their potential application to tumor therapy and tissue repair. DNA Cell Biol.39(2), 167–176 (2020).
   PubMed Web of Science ®Google Scholar
• Ellis L , HammersH , PiliR. Targeting tumor angiogenesis with histone deacetylase inhibitors. Cancer Lett.280(2), 145–153 (2009).
   PubMed Web of Science ®Google Scholar
• Marson CM , MahadevanT , DinesJet al. Structure–activity relationships of aryloxyalkanoic acid hydroxyamides as potent inhibitors of histone deacetylase. Bioorg. Med. Chem. Lett.17(1), 136–141 (2007).
   PubMed Web of Science ®Google Scholar
• Hassig CA , SchreiberSL. Nuclear histone acetylases and deacetylases and transcriptional regulation: HATs off to HDACs. Curr. Res. Chem. Biol.1(3), 300–308 (1997).
   Google Scholar
• Moradei O , MarounCR , PaquinI , VaisburgA. Histone deacetylase inhibitors: latest developments, trends and prospects. Curr. Med. Chem. Anticancer Agents5(5), 529–560 (2005).
   PubMedGoogle Scholar
• Kim H-J , BaeS-C. Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs. Am. J. Transl. Res.3(2), 166 (2011).
   PubMed Web of Science ®Google Scholar
• Zhao C , DongH , XuQ , ZhangY. Histone deacetylase (HDAC) inhibitors in cancer: a patent review (2017–present). Expert Opin. Ther. Pat.30(4), 263–274 (2020).
   PubMed Web of Science ®Google Scholar
• Bubna AK . Vorinostat – an overview. Indian J. Dermatol.60(4), 419 (2015).
   PubMed Web of Science ®Google Scholar
• Connolly RM , RudekMA , PiekarzR. Entinostat: a promising treatment option for patients with advanced breast cancer. Future Oncol.13(13), 1137–1148 (2017).
   PubMed Web of Science ®Google Scholar
• Laubach JP , MoreauP , San-MiguelJF , RichardsonPG. Panobinostat for the treatment of multiple myeloma. Clin. Cancer Res.21(21), 4767–4773 (2015).
   PubMed Web of Science ®Google Scholar
• Bruserud O , StapnesC , ErsvaerE , GjertsenB , RyningenA. Histone deacetylase inhibitors in cancer treatment: a review of the clinical toxicity and the modulation of gene expression in cancer cells. Curr. Pharm. Biotechnol.8(6), 388–400 (2007).
   PubMed Web of Science ®Google Scholar
• Awad SM , ZohnyYM , AliSA , MahgoubS , SaidAM. Design, synthesis, molecular modeling, and biological evaluation of novel thiouracil derivatives as potential antithyroid agents. Molecules23(11), 2913 (2018).
   PubMed Web of Science ®Google Scholar
• El-Naggar AM , Abou-El-RegalMM , El-MetwallySA , SherbinyFF , EissaIH. Synthesis, characterization and molecular docking studies of thiouracil derivatives as potent thymidylate synthase inhibitors and potential anticancer agents. Mol. Divers.21(4), 967–983 (2017).
   PubMed Web of Science ®Google Scholar
• Li Y , WangY , XieNet al. Design, synthesis and antiproliferative activities of novel benzamides derivatives as HDAC inhibitors. Eur. J. Med. Chem.100, 270–276 (2015).
   PubMed Web of Science ®Google Scholar
• El-Kalyoubi SA , TaherES , IbrahimTS , El-BehairyMF , Al-MahmoudyAM. Uracil as a Zn-binding bioisostere of the allergic benzenesulfonamide in the design of quinoline–uracil hybrids as anticancer carbonic anhydrase inhibitors. Pharmaceuticals15(5), 494 (2022).
   Web of Science ®Google Scholar
• Han H , LiC , LiMet al. Design, synthesis, and biological evaluation of 8-mercapto-3,7-dihydro-1H-purine-2,6-diones as potent inhibitors of SIRT1, SIRT2, SIRT3, and SIRT5. Molecules25(12), 2755 (2020).
   PubMed Web of Science ®Google Scholar
• Chin TF , WuWH , LachJL. Comparative hydrolytic rates of N-substituted 6-amino-thiouracils. J. Pharm. Sci.56(5), 562–565 (1967).
   PubMed Web of Science ®Google Scholar
• El-Kalyoubi S , AgiliF. Synthesis, in silico prediction and in vitro evaluation of antitumor activities of novel pyrido [2,3-d] pyrimidine, xanthine and lumazine derivatives. Molecules25(21), 5205 (2020).
   PubMed Web of Science ®Google Scholar
• Mosmann T . Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods65(1–2), 55–63 (1983).
   PubMed Web of Science ®Google Scholar
• Denizot F , LangR. Rapid colorimetric assay for cell growth and survival: modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods89(2), 271–277 (1986).
   PubMed Web of Science ®Google Scholar
• Thabrew MI , HughesRD , McFarlaneIG. Screening of hepatoprotective plant components using a HepG2 cell cytotoxicity assay. J. Pharm. Pharmacol.49(11), 1132–1135 (1997).
   PubMed Web of Science ®Google Scholar
• Al-Rashood ST , HamedAR , HassanGSet al. Antitumor properties of certain spirooxindoles towards hepatocellular carcinoma endowed with antioxidant activity. J. Enzyme Inhib. Med. Chem.35(1), 831–839 (2020).
   PubMed Web of Science ®Google Scholar
• Fournel M , BonfilsC , HouYet al. MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo. Mol. Cancer Ther.7(4), 759–768 (2008).
   PubMed Web of Science ®Google Scholar
• Eldehna WM , HassanGS , Al-RashoodSTet al. Synthesis and in vitro anticancer activity of certain novel 1-(2-methyl-6-arylpyridin-3-yl)-3-phenylureas as apoptosis-inducing agents. J. Enzyme Inhib. Med. Chem.34(1), 322–332 (2019).
   PubMed Web of Science ®Google Scholar
• Yousef RG , SakrHM , EissaIHet al. New quinoxaline-2(1H)-ones as potential VEGFR-2 inhibitors: design, synthesis, molecular docking, ADMET profile and anti-proliferative evaluations. New J. Chem.45(36), 16949–16964 (2021).
   Web of Science ®Google Scholar
• Lo KK-W , LeeTK-M , LauJS-Y , PoonW-L , ChengS-H. Luminescent biological probes derived from ruthenium (II) estradiol polypyridine complexes. Inorg. Chem.47(1), 200–208 (2008).
   PubMed Web of Science ®Google Scholar
• Elkady H , ElwanA , El-MahdyHAet al. New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, anti-proliferative evaluation, flow cytometric analysis, and in silico studies. J. Enzyme Inhib. Med. Chem.37(1), 403–416 (2022).
   Web of Science ®Google Scholar
• Balah A , EzzatO , AkoolE-S. Vitamin E inhibits cyclosporin A-induced CTGF and TIMP-1 expression by repressing ROS-mediated activation of TGF-β/Smad signaling pathway in rat liver. Int. Immunopharmacol.65, 493–502 (2018).
   PubMed Web of Science ®Google Scholar
• Aborehab NM , ElnagarMR , WalyNE. Gallic acid potentiates the apoptotic effect of paclitaxel and carboplatin via overexpression of Bax and P53 on the MCF-7 human breast cancer cell line. J. Biochem. Mol. Toxicol.35(2), e22638 (2020).
   PubMed Web of Science ®Google Scholar
• Elnagar MR , WallsAB , HelalGK , HamadaFM , ThomsenMS , JensenAA. Functional characterization of α7 nicotinic acetylcholine and NMDA receptor signaling in SH-SY5Y neuroblastoma cells in an ERK phosphorylation assay. Eur. J. Pharmacol.826, 106–113 (2018).
   PubMed Web of Science ®Google Scholar
• Ma C , TaghourMS , BelalAet al. Design and synthesis of new quinoxaline derivatives as potential histone deacetylase inhibitors targeting hepatocellular carcinoma: in silico, in vitro, and SAR studies. Front. Chem.9, 725135 (2021).
   PubMed Web of Science ®Google Scholar